This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Well Characterized Biologics & Biological Assays

Savings Deadline Ends In:

  • 00
  • 00
  • 00
  • 00
November 1-3, 2022
College Park Marriott Hotel & Conference CenterHyattsville, Maryland, USA

Tudor Arvinte, Ph.D.
Professor / CEO at University of Geneva Switzerland / Therapeomic Inc.

Agenda Sessions

  • Physicochemical Characterization of Antibodies in Undiluted High-Concentrated Drug Product Solutions and in Concentrations Used in the Clinic – Comparison of the Originator Bevacizumab with a Biosimilar Candidate

  • Advanced Protein Aggregation & Characterization